CDC tackling resistant gonorrhea. The Centers for Disease Control and Prevention Thursday published “Update to CDC’s Sexually Transmitted Diseases Treatment 2010 Guidelines: Oral cephalosporins no longer a recommended treatment for conococcal infections,” in a weekly report.
TMA: Remove abortion advice gag order. Earlier this month, the Texas Medical Association sent a letter to the Department of State Health Services asking that it not be restricted in discussing elective abortion with patients, even if the patient asked about it or if the standard of care indicated it should be discussed as an option.
TMA President Dr. Michael E. Speer, said DSHS’s proposed rules would impose a “gag order” on physicians who participate in the Texas Women’s Health Program.
“If the state indeed wants doctors to participate in the program, this is a step in the opposite direction,” Speer said.
TMA officials said many Texas physicians may leave the program “because the rules, if enacted, would force them to choose between practicing medicine in accordance with the standard of care and medical ethics, or in accordance with a rule created to serve a political ideology.”
The American College of Obstetricians and Gynecologists/Texas District, Texas Association of Obstetricians and Gynecologists, Texas Academy of Family Physicians, and Texas Pediatric Society all signed the letter.
At-risk men and women advised to take HIV prevention pill. The HIV prevention pill that was advised for use in gay and bisexual men is being recommended by the CDC for at-risk women and heterosexual men. In a study, the drug Truveda had cut the risk of HIV infection by 44 percent in healthy gay and bisexual men along with condom use and counseling.
Statin’s benefits outweigh diabetes risk. Researchers concluded that the effectiveness of cholesterol-lowering statin drugs far outweighed diabetes risk in the journal Lancet, published Thursday. In a 2008 clinical trial involving more than 18,000 adults, there was a small increased diabetes risk, however, the drug provided a protective affect against heart attacks, strokes and heart diseases deaths. The Food and Drug Administration had previously required the makers of such drugs to carrying a warning sign about the diabetes risk.